Science & Tech
After COVID vaccines, time to use mRNA tech against other infectious diseases
After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media
March 12, 2022
Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.
But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "
There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.
Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.
More For You
- YouTube
For many in Iran, it’s a waiting game for how long Ayatollah Khamenei has left to live.
Most Popular
An army soldier stands guard at a post at the Friendship Gate, following exchanges of fire between Pakistan and Afghanistan forces, at the border crossing between the two countries in Chaman, Pakistan February 27, 2026. Picture taken with a mobile phone.
REUTERS/Abdul Khaliq Achakzai
In a 30-minute call on Thursday, President Donald Trump reportedly told Ukrainian President Volodymyr Zelensky he wants to end the war with Russia as soon as possible — aiming for a deal by summer, but ideally within weeks.
Former British ambassador to the U.S. Peter Mandelson leaves his residence after he was released following his arrest by London police on Monday on suspicion of misconduct in public office, following the release of U.S. Justice Department files linked to the late financier and convicted sex offender Jeffrey Epstein, in London, Britain, February 26, 2026.
REUTERS/Toby Melville
The ghost of Jeffrey Epstein continues to haunt the world.
Think you know what's going on around the world? Here's your chance to prove it.
© 2025 GZERO Media. All Rights Reserved | A Eurasia Group media company.